Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company SurgiMab S.A.S.
DescriptionFluorescent injectable conjugate based on a chimeric antibody specific for ovarian tumors
Molecular Target
Mechanism of ActionImaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationCancer, Diagnostic
Indication DetailsImaging agent for ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today